Your browser doesn't support javascript.
loading
Connexin 32 downregulation is critical for chemoresistance in oxaliplatin-resistant HCC cells associated with EMT.
Yang, Yan; Yao, Jing-Hao; Du, Qian-Yu; Zhou, Yong-Chun; Yao, Ting-Jing; Wu, Qiong; Liu, Jing; Ou, Yu-Rong.
Afiliação
  • Yang Y; Department of Medical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, People's Republic of China.
  • Yao JH; Department of Medical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, People's Republic of China.
  • Du QY; Department of Medical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, People's Republic of China.
  • Zhou YC; Department of Radiation Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, People's Republic of China.
  • Yao TJ; Department of Surgical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, People's Republic of China.
  • Wu Q; Department of Pathology, The First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, People's Republic of China.
  • Liu J; Department of Medical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, People's Republic of China.
  • Ou YR; Department of Pathology, The First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, People's Republic of China.
Cancer Manag Res ; 11: 5133-5146, 2019.
Article em En | MEDLINE | ID: mdl-31213923

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article